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ABSTRACT 
 
Peri-implant mucositis is a silent inflammatory condition that is destructive in nature 
affecting only the soft tissues in the vicinity of dental implants. The current line of treatment 
includes the use of systemic antibiotics, mechanical debridement using LASER decontamination, 
the use of mouthwash or oral rinsing with chlorhexidine, maintenance and improvement of oral 
hygiene, mechanical debridement with or without systemic antibiotic treatment, mechanical 
debridement with or without the use of local drug delivery systems. However, these treatments do 
not solve the problem of implant rejection as peri-implant mucositis progresses to per-implantitis 
which causes severe bone loss and ultimately leading to implant rejection thus causing a great 
amount of inconvenience to the patient leading to a reduction in patient compliance. Local 
delivery of doxycycline may decrease the systemic toxicity of the drug and can also save time 
and money for the patient in the long run. The aim of my study is to formulate and characterize 
the release of doxycycline from the polymer matrix and also to reduce the systemic toxicity of 
doxycycline owing to the localized nature of the formulation. To achieve this goal, the titanium 
implants were coated in layer by layer fashion using an alternate combination of Hyaluronic acid 
and Chitosan to get a controlled release of doxycycline over a two-week period. The objective of 
my study was to develop layer by layer antibacterial coatings based on the principle of ionic 
gelation over the surface of titanium implants loaded with doxycycline using chitosan, 
hyaluronic acid, polycaprolactone Poly-lactic glycolic acid based on a layer by layer self-
assembly technique for the prevention of periodontal infections. 
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CHAPTER 1 
INTRODUCTION
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Dental implants for the past several decades have been used as a Gold Standard for the 
replacement of missing tooth1. Basically, two types of implants are available in the market one is 
made primarily of titanium whereas the other is made up of zirconium. Apart of titanium and 
zirconium, a number of other elements too are present in the dental implants with each serving a 
specific purpose. Aluminum incorporated into dental implants reduces the specific weight of the 
dental implant. Vanadium present decreases the thermal conductivity of the implants. Zirconium- 
based implants are white in color whereas titanium-based implants are grey in color2,3. This makes 
zirconium aesthetically and cosmetically more acceptable than titanium. In spite of these cosmetic 
drawbacks, titanium has been a material of choice for the manufacture of dental implants owing 
to its biocompatibility with human tissue coupled with great mechanical properties4. Apart of 
titanium and zirconium, a number of other elements too are present in the dental implants with 
each serving a specific purpose. Aluminum incorporated into dental implants reduces the specific 
weight of the dental implant. Vanadium present decreases the thermal conductivity of the implants. 
Even with a success rate of about 90%, there still have been instances of peri-implant mucositis 
infections in a number of patients5. The infection around the implant is primarily due to gram-
negative anaerobic bacteria which ultimately leads to implant rejection and the resulting 
complications 5,6. In order to address this issue, a number of therapeutic avenues are available 
which include surgical removal of the tissue, treatment with anti-biotic and laser therapy against 
potential pathogens to facilitate the re-osseointegeration of the implant and thus ensure the 
success of the therapy6. The bacterial adhesion on the surface of implant followed by biofilm 
formation is the root cause of implant rejection by the patient. The presence of biofilm renders 
any treatment with antimicrobials or even by hosts’ defenses mechanism fruitless as the biofilm 
is a self-sustained in its nutrition and blood supply3,7. In spite of strict laboratory procedures like 
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strict surgical sterile protocols to eradicate the instance of implant rejection due to bacteria which 
are already present in the oral environment. The route through which the bacteria attaches itself 
to the surface of the implant is from the soft and hard tissue of the gum cavity8.It is this surface of 
the dental implant which has to be coated with a layer by layer coat of individual polymers as it is 
susceptible to bacterial attachment and consequently leading to biofilm formation9. Inhibition of 
initial bacterial adhesion over the surface of the dental implant is one of the best ways of 
preventing biofilm formation3,9. My research focusses primarily on preventing bacterial adhesion 
and further biofilm formation through the principle of ionic gelation of oppositely charged 
polymers loaded with doxycycline in a layer by layer fashion for sustained drug delivery. 
 
 
A-1 Etiology of Peri-implant mucositis: 
 
This condition is characterized as a site specific10 inflammatory destruction of only the 
soft and surrounding the dental implants11. Peri-implant mucositis and peri-implantitis are 
associated terms which are closely related to each other but the impact they have on the 
supporting bone is different. Peri-implantitis causes considerable loss of horizontal and vertical 
bone with various signs and occurs after osseointegeration has been achieved whereas peri-
implant mucositis gives no signs of loss of supporting bone12. Many efforts have been made to 
understand the pathophysiology of the disease but the exact cause has not been identified. A 
number of associated factors like poor oral hygiene, smoking, diabetes are known to be 
implicated in periodontal and peri-implant infection12,13. Patients suffering from peri-implant 
mucositis are more prone to suffer from, failure of implant therapy, reduced compliance, extra 
costs, discomfort 13–15. Spirochetes and other gram-negative anaerobes are known to be 
associated with it 10. These gram-negative anaerobes include Prevotella intermedia, 
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Porphyromonas gingivalis, Aggregatibacter actinomycetemcomitans, Bacteroides forsythus, 
Treponema denticola, Prevotella nigrescens, Peptostreptococcus micros, and Fusobacterium 
nucleatum 10,16. These micro-organisms are sensitive to doxycycline hyclate in vitro at a 
concentration of ≤10µg/ml17.Interleukin levels too are elevated in patients suffering from peri- 
mucositis5. Interleukin-10 has been observed in high concentrations in peri-implant mucositis 
patients5, higher levels of IL-1 and IL-6 too have been observed which are thought to be 
implicated in tissue destruction5,18.Inadequate distribution of pressure on the tissue surrounding 
the implants has also been implicated with peri-implant mucositis10,19. Osseointegration is used 
as a quantitative and qualitative yardstick to evaluate the success of implant therapy 10. 
A-2 Management of Peri- implant mucositis: 
 
The goal of current peri-implant mucositis treatment is to ensure successful 
osseointegration of the implant into the oral cavity and to prevent the incidence of microbial 
infection that is associated with it. Oral hygiene is a key to the success of implant-based therapy 
coupled with following good healthy habits. Even before the implant therapy is started, the 
patient is advised to take a high dose of anti-biotic as prophylactic measure. Detoxifying the 
surface of the implant is a great step towards ensuring the success of implants over a long-term 
but mechanical detoxification isn’t enough to detoxify the surface of dental implant20,21. This 
means that cleaning an implant is not a monotherapy but is a dual therapy. Chemical 
decontamination of the dental implants is done with the objective to disrupt bacterial plaque 
biofilm, detoxify cell components affecting growth on the implant surface, reducing bacterial 
load by diluting to a level that will allow healing, with the goal to eliminate bleeding upon 
probing, reduce or eliminate possible bacterial population on the implant and to stabilize bone 
levels20. There is no reliable treatment to treat peri-implant disease but it doesn’t mean that 
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current treatment doesn’t work22. Curettes are used to mechanically detoxify the surface of 
dental implants, but it must be borne in the mind that these curettes must be softer than the 
implant itself that is ideally made up of plastic, carbon fibres or gold curette. If the curette 
damages the surface of the implant then it can damage the oxide layer causing an alteration in 
the surface chemistry and the biocompatibility of the implant may be compromised. From a 
chemical point of view, sodium hypochlorite (0.25%), a common household bleach can be used 
to as an antiseptic. There has been an 80 fold decrease in biofilm endotoxin when compared 
with water, it is present naturally in the neutrophils, macrophages & monocytes, there is no 
histological effect on periodontal healing, it doesn’t corrode the implants and also is accepted as 
a mouthwash by FDA23. A sequential therapy has been developed to effectively prevent the 
instance of peri-implant mucositis, this therapy includes a combination of mechanical therapy, 
anti-septic therapy, antibiotic therapy and surgical therapy24. The antibiotic treatment focusses 
on reducing the bacterial population thus, in turn, reducing inflammation. The problem of 
recolonization of implant surface is seen as soon as antibiotic therapy is stopped and true 
osseointegration is not achieved25. Antibiotics like doxycycline, minocycline, metronidazole, 
amoxicillin, etc. are most commonly used to treat peri-implant mucositis infections5,26,27. 
Corsodyl gel 1%w/w is used to treat problems associated with gum like reddening, swelling, 
bleeding etc. The Corsodyl gel contains chlorhexidine digluconate has a rapid mechanism of 
action by acting in just 30 seconds killing all the bacteria and preventing the growth of bacteria 
further by forming an anti-bacterial coating over teeth and gums which is protective in nature. 
This anti-bacterial coating prevents plaque buildup for about 12 hours. 
A-3 Doxycycline hyclate: 
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Doxycycline hyclate is a salt form of doxycycline which is a second-generation tetracycline 
and the only tetracycline which is eliminated from the body via both urine and faeces. Because of 
its superior pharmacokinetics and a safer profile as compared to other tetracyclines, it is widely 
used in the treatment of peri-implant mucositis and other bacterial infections in general. 
 
Molecular structure of Doxycycline hyclate 
 
Empirical Formula: (C22H24N2O8•HCI)2•C2H6O•H2O 
 
Doxycycline is available in the form of 75mg and 100 mg delayed-release tablets and also 
as 100mg and 200mg capsules. Doxycycline exhibits its bacteriostatic effects by inhibiting protein 
synthesis by binding to the bacterial ribosomes thus, preventing the connection between amino- 
acyl t-RNA and 30s ribosomal subunit28. The bioavailability of doxycycline lies between 95% to 
100%. Doxycycline shows a plasma protein binding of about 80% to 90%29. Doxycycline doesn’t 
undergo metabolic transformation in the body and is excreted as it is in urine, faeces29. The 
partition coefficient of doxycycline is 0.6329. Doxycycline is a lipophilic molecule and shows 
excellent tissue distribution29.Doxycycline shows its antibacterial effect by binding to 30S 
ribosomal subunit and thereby preventing protein synthesis by the bacteria. The most common 
side effects seen are nausea, vomiting, diarrhea and other effects may include difficulty in 
swallowing, teeth staining, change in the amount of urine, rapid clearance and metabolism and 
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intracranial hypertension28,30. Intracranial hypertension may lead to sudden loss of vision, blurred 
vision and severe headache. 
 
 
A.4 The hydrophobic polymers used to provide a sustained release of Doxycycline hyclate: 
 
A.4.1 Poly-Lactic glycolic acid (PLGA): 
 
 
PLGA is a biodegradable and a biocompatible polymer having a wide range of biomedical 
and Pharmaceutical applications. PLGA is synthesized from two monomers namely Polylactic acid 
(PLA) and Polyglycolic acid (PGA). The ratio of Poly-lactic and poly-glycolic acid can be 
changed to control the Physiochemical and pharmacokinetic properties of PLGA. Poly-lactic acid 
is more hydrophobic than Polyglycolic acid because of the presence of methyl side groups31. Thus, 
if the presence of polylactic acid is higher than poly-glycolic acid, it makes PLGA a hydrophobic 
molecule and vice versa. A higher proportion of Poly-lactic acid makes PLGA more hydrophobic 
thereby slowing down the degradation rate of PLGA. Properties like the ratio of Lactide: Glycolide, 
initial molecular weight as well as storage conditions influence the physical properties of PLGA31. 
A dose-dependent and a non-linear profile is followed by PLGA in its pharmacokinetic and bio 
distribution profile31. PLGA is insoluble in water but freely soluble in organic solvents like 
methylene chloride, toluene, acetic anhydride etc. 
A.4.2 Polycaprolactone: 
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Polycaprolactone is a biodegradable aliphatic polyester synthesized by ring opening 
polymerization of ε-Caprolactone, having a wide range of pharmaceutical and biomedical 
applications. Polycaprolactone shows strong mechanical properties, slower degradation rates as 
well as poor cellular adhesion. The structural configuration of polycaprolactone determines its 
degradation rate32. Polycaprolactone based root canal filling under the trade name “Resilon” is 
being actively marketed and has many marked advantages in being biodegradable and non-toxic. 
 
 
A.5 Layer by layer delivery of doxycycline hyclate for the prevention of peri-implant 
mucositis: 
The layer by layer local delivery of doxycycline is a type of surface modification which 
has proven to be efficacious and therapeutically viable option9,33. With this method, a sustained 
delivery of doxycycline hyclate has been achieved. The polymer combination primarily used was 
chitosan and hyaluronic acid on account of their charge difference as well as their biocompatibility 
with the human body9. Hyaluronic acid is an anionic, nonsulfated glycosaminoglycan found in 
various tissues throughout the human body34. A healthy human body possesses about 10 to 100 
grams of hyaluronic acid out of which about 33% is synthesized and eliminated on a daily basis34,35. 
The process of wound healing is promoted by hyaluronic acid. A wounded tissue produces 
hyaluronic acid in a higher quantity than normal36. Hyaluronic acid has a very short half-life of 
about 2 to 6 minutes and is quickly removed from circulation by the human body35. Hyaluronic 
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acid is excreted via lungs, hepatic elimination as well as kidney and the gastrointestinal tract with 
pulmonary and hepatic elimination dominating the excretion pathway35. Chitosan is a linear 
polycationic natural polysaccharide which is derived from chitin37. Chitosan has been used in 
various drug delivery platforms on account of its biocompatibility, non-toxicity, mucoadhesive, 
biodegradability as well as it does not elicit an antigenic response from the human body28,37. It is 
hypothesized that low molecular weight chitosan inhibits bacterial DNA transcription as well as 
mRNA synthesis by traversing bacterial cell wall and binding to the bacterial DNA37,38. It has been 
proved that gram-negative bacteria interact to a larger extent with low molecular weight chitosan 
as compared to gram-positive bacteria on account of their higher hydrophilicity and negative 
charge on the cell surface37. Low pH favors binding of chitosan to the bacterial cell wall as well 
as enhances the polycationic nature of chitosan37,39. Lowering of molecular weight of chitosan 
improves the selectivity of chitosan towards gram negative bacteria as well as the activity of gram- 
positive bacteria is reduced considerably37. 
Thus, the objective of the present study was to develop a layer by layer antibacterial and 
anti-inflammatory coating loaded with doxycycline hyclate over the surface of titanium implants 
using chitosan, hyaluronic acid, polycaprolactone and PLGA in a layer by layer technique. We 
hypothesize that the layer by layer coating over the titanium implants will sustain release of 
doxycycline hyclate over a longer period of time and in turn, will reduce the rate and extent of 
bacterial biofilm formation over the implant surface. 
A.6 Dental implants: 
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Figure.1 Components of dental implant40 
 
The research into the development of dental implants has risen tremendously in the past 
few years41. The main purpose of using dental implants is to promote osseointegration of the teeth 
with the gum cavity5. Osseointegration is a process by which, the implant locks and attaches itself 
to the bone in the gum thus forming a strong anchor between the artificial tooth and the bone5. 
Dental implants have a very high success rate but the chance of infection due to bacteria especially 
gram-negative already present in the hard and soft tissue of the oral cavity is also high which can 
lead to failure of therapy5,42. The risks and failure of dental implant surgery can be broadly be 
classified into three broad categories which are first during surgery (excessive bleeding, nerve 
damage), secondly after 6 months of surgery (infection or failure to Osseo integrate) and finally 
the long-term factors which include peri-implant mucositis, peri implant-mucositis or mechanical 
failures43–45. It has been seen that through surface modification of dental implants, the success of 
implant therapy has been improved the following thesis will educate its readers on various aspects 
of dental implants like its history, its clinical use, and the properties of dental implants. 
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A.7 Types of dental implants: 
 
American dental association recommends two types of dental implants (Endosseous 
&Subperiosteal) for safe use but there are three different types of dental implants present in the 
market46,47. 
1) Transosteal implants: These kinds of implants are available in the market in two different forms 
namely U-shaped frame form or metallic pin form. When placed in the mouth, they pass 
through both jawbone and gum cavity47. 
2) Endosseous implants: These kinds of implants are available in the market in the form of 
cylinder, blade or screw shape and are made up of primarily of titanium, zirconium and its 
alloys47. The site of implantation of this type of implant is in the jaw bone and deeper the bone 
in the mandible and maxilla, longer the implant will be. 
3) Subperiosteal implants: This type of implant is attached between the jaw bone and the gum 
tissue47. Subperiosteal implant comprise of a metallic framework47. 
 
 
A.8 Influence of surface properties in the long-term success of dental implant-based 
therapy: 
The surface properties of the dental implant play a key role in the long-term success of 
implant-based treatment. Surface properties like surface topography, surface wettability, surface 
free energy have a significant impact on cellular adhesion, differentiation, spreading as well as the 
production of local mediators of inflammation48–52. Surface properties determine the rate and the 
extent of osseointegration of dental implants53. Biomaterials like dental implants are often in 
contact with biological fluids and, there lies a relative movement between the solid and liquid 
phases, this movement is referred to as “Dynamic Wetting”48. Surface properties have a 
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significant impact on the interfacial reactions occurring between the implant surface and 
physiological fluids as well as bone formation in vivo48,54,55 . The initial bio response to the 
implanted dental implant depends upon the surface micro and nano topographical properties along 
with the surface wettability48. The following surface properties influence the clinical success of 
dental implant-based therapy. 
A.8.1 Surface topography: 
 
The microscopic and macroscopic properties of dental implants are referred to as surface 
topography56.The cellular response of the human body to the dental implant depends upon the 
surface topography of the dental implant 57 58 59 60. In cases where there is no adequate bone 
at the site of implantation, those dental implants can be used whose surface characteristics have 
adequately been optimized. The optimization of the surface of dental implants is done through 
various surface treatments for rapid and long-lasting osseointegration 57 61. The terms roughness 
and topography can be used interchangeably with each other. Dental implants with adequate 
roughness may improve the bone to implant contact, increase the torque removal force and also 
has an impact on the primary stability of implants 56,62. Since surface topography of the implant 
is primarily responsible for the bone to implant contact, it has to be modified56. The surface of the 
dental implant can either be made porous or through surface modification made more 
hydrophilic56,63. Implant surface roughness can broadly be divided into three main categories 
mainly macro, micro and nano roughness56. By appropriately adjusting the micro-roughness of the 
dental implant, the long-term success of dental implant has been noted56,62. The rate of 
osseointegeration of the dental implant in the oral cavity is determined by adsorption of proteins 
and adhesion of osteoblastic cells over the surface of the dental implants56,64. The proliferation and 
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differentiation of osteoblastic cells are largely affected by the nano-topography of the dental 
implants65. 
 
A.8.2 Surface Wettability: 
 
Surface wettability is an important property associated with titanium oxide-based dental 
implants66. Surface wettability is also used interchangeably with the terms hydrophilicity and 
hydrophobicity53. Hydrophilic surfaces are superior to hydrophobic surfaces in terms of interaction 
with biological fluids, cells and tissues thus ensuring better success rates of implant therapy53,67. 
Most of the implants that are being marketed are hydrophobic in nature 66,68. The surface roughness 
of the dental implants is also a factor that imparts hydrophobic character to the implants69. The 
surface wettability of dental implants is quantified in terms of contact angle, which is the angle 
between the tangent line to a liquid drop’s surface at the three- phase boundary and the horizontal 
solid’s surface66. It has been observed that the success of dental implants is associated with 
wetting of the implants and so to improve the process of wetting, the surface tension of implants 
has to be increased70. The phenomenon of wetting is influenced by the energy of the solid surface 
and that of the surface tension of the liquid58,70–72. Solid surfaces having high energy coupled with 
liquids having low surface tension favors the process of wetting70. During the process of wetting, 
the total energy of the system is reduced until it reaches an equilibrium stage also called 
“Metastable equilibrium stage”68. Surfaces with wetting tension more than 30 mN m−1 are 
generally classified as hydrophobic whereas those with a surface tension less than 30 mN m−1 are 
classified as hydrophilic in nature48. Water because of its ability to form hydrogen bonds, has a 
high surface tension of 73 mN m−1 68. Phosphate buffer has a surface tension of 69.5 mN m−1. The 
surface tension of blood is 52 mN m− 1 which is further lower than water 68,73. The surface tension 
of saliva lies between the range of 53.4 mN m−1 to 63.2 mN m−1 68,73,74. 
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Implant tissue interaction and osseointegration of the implant is affected by the 
hydrophilicity of the surface of the implant as well as the surface composition of the dental 
implant53. Hydrophilic surfaces interact to a larger extent with biological fluids, cells and tissues 
as compared to hydrophobic surfaces53. It has been seen that the hydrophilization of the surface of 
dental implants, improves the initial blood contact, promotes wound healing and thus, in turn, 
promotes the overall process of osseointegration48. 
 
A.8.3 Surface Charge: 
 
The aspect of surface charge influences the way in which cells adhere to the implant surface 
as well as other activities necessary for proper osseointegration 75. The surface if titanium-based 
dental implants have an overall positive charge which makes it ideal for adhesion of negatively 
charged cells to the surface of the implants76. Layer by Layer surface treatment of dental implants 
alters the surface charge of dental implants by coating oppositely charged polymers over each 
other based on the principle of ionic gelation so as to mimic the natural processes involved in 
osseointegration. 
 
 
A.8.4 Surface Chemistry: 
 
Protein adsorption and the consequent cellular adhesion and proliferation is greatly affected 
by the surface chemistry of the dental implants75. The carbon nanotubes present on the surface of 
dental implants have a positive impact on cellular division and the subsequent proliferation which 
in turn is necessary for osseointegeration75,77–80. Fibronectin adsorption, endothelial cell adsorption 
and growth as well as corneal cell migration is highly influenced by variations in the surface 
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chemistry of dental implants76,81,82. The surface chemistry of dental implants can be characterized 
using X-ray photoelectron spectroscopy (XPS), a method which analyzes the chemical 
composition of different groups on the dental implants83. 
 
A.8.5 Surface Energy: 
 
The process of osteogenesis is regulated by the surface free energy of the dental implants83. 
Surface properties such as chemical composition of the surface, surface charge, surface micro- 
topography have an impact on the surface energy 53. Currently available dental implants in the 
market are hydrophobic in nature on account of their surface roughness69.Contamination in any 
form causes a reduction in the surface free energy of the dental implants83,84. Surface free energy 
has a profound effect on protein adsorption process which in turn influences the cellular response 
to the injected dental implant85. The surface energy is reduced when contaminants combine 
strongly with the dental implants48. Thus, a strong emphasis has to be placed on maintaining 
cleanliness of dental implants during handling and also during storage. Initial stages of tissue 
healing after implant surgery is largely affected by the surface energy as well as the cleanliness of 
the dental implants48,86. The critical polar portion (yp) and surface tension are ideal parameters that 
indicate the surface free energy of the implants and the presence of organic contaminants on the 
sample86. A lowering of surface tension intercept and a polar portion of the implant indicates the 
presence of organic contaminants and reduction in the surface energy of the implants and vice 
versa86. The implants thus have to be sterilized in such a way that there is no significant reduction 
in the surface energy. Methods like dry heat sterilization have no effect on the surface energy of 
the implants whereas, on the other hand, UV treatment resulted into the elevation of the surface 
energy of the dental implants with a higher disposition for biological reactivity resulting into 
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cellular adhesion and successful implant fixation86. The structural arrangement of proteins and the 
adsorption of proteins on the surface of dental implants is also influenced by the surface energy of 
dental implants53. 
 
A.9 The oral environment surrounding the dental implant: 
 
A.9.1 Saliva: 
 
The dental implants get coated with salivary components as soon as the implant it fixed at 
it sire in the oral cavity 87. Saliva provides the necessary proteins and other nutrients necessary for 
bacterial growth over the implant surface to support the formation of bacterial biofilm and bacterial 
metabolism87–89. The physio-chemical and surface properties of the implant changes because the 
continuous saliva movement over the implant surface thus forming a coat made up of saliva. This 
coat facilitates bacterial adhesion by forming specific receptors which finally promote bacterial 
adhesion to the implant surface87. The presence of salivary esterase’s like albumin, alpha-amylase 
etc. are known to degrade the resins of the dental implants 87,90. The hydrolytic activity of these 
esterase’s is known to be potentiated by the presence of cariogenic microbes present in the oral 
cavity87,91. 
A.9.2 Proteins: 
 
The initial attachment of bacteria to the titanium surface is dictated by the ions and proteins 
derived from blood76. Adhesion proteins like fibrinogen, fibronectin, vitronectin, Von 
Willebrand’s factor strongly influence the initial interaction of the implant surface with biological 
fluids, tissues and bone76 . The adhesion of proteins to the surface of the implants is strongly 
affected by the adsorbed proteins76. The amount of cells adsorbed onto the surface of the implant 
is related to the amount of protein adsorbed76. 
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A.10 The process of biofilm formation: 
 
The process of biofilm formation is a highly complicated and multi-stage process during 
which micro-organism transforms to a sessile growth form from planktonic growth form92,93. 
Specific genes are implicated in the formation and subsequent establishment of biofilm on the 
surface of dental implant92–94. The host defense mechanisms, as well as antibiotic therapies, offer 
little to no therapeutic outcome against bacterial biofilms5. The major source of nutrition and 
energy for the biofilm is saliva with saliva itself being a high source of micro-organisms5. The 
bacteria that attach to the surface of the dental implant, secrete chemicals like extracellular 
polysaccharides coupled with some adhesion structures which facilitate the process of biofilm 
formation5,95,96. The bacterial species responsible for biofilm formation communicate with each 
other through a special mechanism called “Quorum Sensing”93,97. Quorum sensing directly 
regulates the process of biofilm formation5,98. The process of biofilm formation begins within a 
few hours as soon as an implant is placed in the oral cavity, a process which is further facilitated 
by saliva and presence of food particles5. Biofilms are majorly composed up of water with 
additional components like DNA, RNA, polysaccharides, proteins, enzymes as well as some 
extracellular polymeric substances93. The reason why biofilms are resistant to everyday antibiotics 
is that the biofilm-forming bacteria switch on certain genes which in turn get converted to resistant 
phenotypes on account of changes in pH, osmolarity, nutrition, temperature etc. 93,99. Secondary 
metabolites are produced by the bacteria in the biofilm during the process of biofilm formation 
which in turn play the role of a signaling molecule to further promote the process of biofilm 
formation93. The process of formation can be summarized briefly into the following steps a) 
Attachment to surface b) Micro-colony formation c) Final maturation and detachment5,100. The 
initial attachment phase is a reversible one wherein a solid-liquid interface exists between the 
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micro-organism and the implant surface5,93. A rough, hydrophilic environment provides an ideal 
environment for biofilm formation93. Biofilm formation is potentiated by the presence of special 
cellular structures of bacteria like flagella, pili, fimbriae, polysaccharides 93,101. The subsequent 
step of micro-colony formation takes place after the attachment is successful, and a series of 
chemical signals promote biofilm growth and maturation93,102. In the maturation phase, water 
channels are formed within the biofilm matrix, which promotes the growth of biofilm by removing 
waste materials from the biofilm matrix and at the same time providing essential nutrients for 
sustaining the biofilm93,103. The final phase of detachment can be due to two reasons firstly as a 
part of the natural process and secondly due to mechanical stress within the biofilm which makes 
the bacteria leave the biofilm matrix to mature and multiply elsewhere93,100. As soon as the bacteria 
are ejected from the matrix of the biofilm, they cease the production of enzymes and other 
polysaccharides93. The cells in the biofilm inherit certain properties from the biofilm-like antibiotic 
resistance, multiplication etc93 which make traditional antibiotic therapy useless on account of 
poor penetration of antibiotics into the biofilm matrix93. 
 
 
 
 
Figure.2. Process of biofilm formation 
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A.11 Hypothesis & Specific Aims: 
 
We hypothesize that by coating the dental implant in a layer by layer fashion with a 
combination of polymer, we can achieve a sustained delivery of doxycycline hyclate over a period 
of two to three weeks and at the same time ensure that the process of osseointegration progresses 
smoothly without bacterial infection hindering it. 
Aim 1: To achieve a drug concentration of higher than 10 µg/ml every day, the minimum 
inhibitory concentration of doxycycline hyclate required to inhibit the growth of gram- 
negative anaerobic bacteria. 
In order to achieve this, different amount of drug concentrations was loaded in the 
chitosan solution ranging from 375 mg to 600 mg. The release was characterized by conducting 
in vitro release studies. The solubility of doxycycline hyclate was also analyzed in water during 
this study. 
Aim 2: To find the optimum concentration of individual polymers for coating the dental 
implants. 
A number of concentrations were studied for ranging from 1% to 6%, in the end, 4% 
concentration of hyaluronic acid, chitosan was chosen because the viscosity was neither too high 
nor too low. A concentration of 4% was chosen for PLGA in methylene chloride and a 
concentration of 5% polycaprolactone in methylene chloride was chosen based on the similar 
criteria of viscosity and solubility. 
Aim 3: To evaluate the hydrophilic/hydrophobic nature of coated as well as uncoated 
titanium disc 
This study was conducted because hydrophilic implants have a higher success rate when 
compared with hydrophobic implants. As the hydrophilic character increases, the interaction with 
20 
 
blood, tissues, bones and other biological fluids also increases. Thus, a contact angle of smaller 
than 90 º indicates that the implants are hydrophilic in nature.
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CHAPTER 2 
MATERIALS AND METHODS 
 
 
22 
 
Titanium implants were obtained from Branemark System of different sizes in 
collaboration with the University of Tennessee Health Sciences Centre. Low molecular weight 
water-soluble chitosan was obtained from Carbosynth Limited. Polycaprolactone having 
molecular weight 25,000 was purchased from Polysciences Limited. Doxycycline hyclate 
(>/98%) HPLC grade was purchased from Sigma-Aldrich life sciences. Hyaluronic acid 
sodium salt- low molecular weight 40,000 to 50,000 was purchased from Carbosynth Limited. 
Titanium disc of medical grade was obtained from Sigma Aldrich. PLGA (50:50) was 
obtained from Durect Corporation, Cupertino, California. 
B.1 Fabrication of multi-layer polymer coatings onto the titanium implant surface: 
 
The implants were coated keeping in mind the aspect of surface charge. The titanium-
based implants have an overall positive charge so the obvious layer of choice is 4% hyaluronic 
acid, a polyanionic polymer. The charge difference promotes adhesion of hyaluronic acid to 
the surface of the dental implant. The coating cycle had to be optimized in order to ensure 
proper and efficient coating of the implants. Soon after coating the surface of the implants 
with hyaluronic acid, the polymer coating was dried with a cool air using an air blower so as to 
ensure that maximum amount of polymer got dried before proceeding to the step of vacuum 
drying. Air drying was performed for a longer time so as to ensure that vacuum drying did not 
cause any cracking of the polymer film. Vacuum drying was done soon after air drying for 4 
to 6 hours continuously to remove all the solvent molecules from the polymer coat. This 
process was repeated again in a cyclic manner again with chitosan 4% solution. 
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B.2 Preparing Chitosan (LMWWS)-Doxycycline hyclate complex: 
 
Low molecular weight water-soluble chitosan was used for the preparation of a 4% solution 
of the polymer in water. Dissolution of the polymer was achieved through mild heating and vortex 
mixing. To this 4% polymer solution, 375 mg doxycycline hyclate was added and the solution was 
subjected to mixing at a speed of 50rpm on a magnetic stirrer for 30 minutes. The resulting solution 
was a clear yellow colored solution which has to be stored under refrigeration. 
 
 
B.3 Scanning Electron Microscopy: 
 
The nanotube dimensions were verified using Field Emission Scanning Electron 
Microscopy (FESEM) (JEOL-JSM 6320F). The scanning electron microscope (SEM 15 kV, 
Cambridge 360) was used to characterize the polymer coated dental implants in terms of atomic 
composition, coating thickness and morphology. Implant surface. Implant surface morphology 
alterations were identified by SEM (Carl Zeiss EVO 40, Peabody, Massachusetts, USA) at the 
UTHSC College of Dentistry Laboratory of Bioscience Research, Memphis, Tennessee, USA. The 
implants were secured to the STEM sample holders and they were fully inspected by the SEM at 
20 kV at 50x magnification for damage inspection. SEM analysis was conducted to verify the 
success of the coating procedure. Elemental analysis was also performed along with SEM analysis 
to check the levels of individual elements before and after the coating process. 
 
 
B.4 In-vitro drug release studies: 
 
The release studies were carried out in 2 ml Eppendorf tubes in a release medium consisting 
of phosphate buffer having pH 7.4, 6 and 5 respectively. The release studies were done to mimic 
the pH of the biological fluids present in the oral cavity like saliva and blood whose pH is 6.8 and 
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7.4 respectively. The Eppendorf tubes were then suspended in a water shaker bath (Precision, 
ThermoFisher, USA) at a temperature of 37 degree Celsius and at a shaking speed of 80rpm to 
mimic physiological conditions. On the first day, the release medium was replaced after every hour 
to check for burst release of doxycycline from the polymer matrix. The release medium was 
replaced on a daily basis to plot the release profile curve. The released drug was analyzed using 
UV spectrophotometry at 353 nm. 
 
 
B.5 UV Spectrophotometry: 
 
UV spectrophotometry was used for drug release study. The blank used for this study was 
phosphate buffer. The calibration curve was plotted at 353 nm and the UV measurements were 
carried out at 353nm. For the preparation of the calibration curve, a 1mg/ml solution of 
doxycycline hyclate was prepared by dissolving 50mg doxycycline hyclate in 50 ml water. 
B.6 pH meter: 
 
For preparing buffers of different pH, Cole-Parmer P-200 pH meter with electrode holder 
was used. The instrument has to be calibrated every day before it is used to prevent errors from 
past interfering with current results. Standard solutions of known pH were used for calibration of 
the equipment. 
B.7 In-vitro release of doxycycline hyclate from polymer matrix: 
 
The release studies were conducted on 25 polymer and drug-coated dental implants with 
the release medium being phosphate buffer of different pH at a physiological temperature of 37- 
degree Celsius in order to assess the effect of pH on the release of doxycycline from the polymer 
matrix. 
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B.8 MTT Assay: 
 
The metabolic activity of living cells was evaluated using MTT (3-(4,5-dimethylthiazol-2- 
yl)-2,5-diphenyltetrazolium bromide) tetrazolium assay. Various reductase enzymes like 
mitochondrial reductase, NAPH reductase etc. reduce MTT to a purple insoluble compound called 
as Formazan. The insoluble formazan is solubilized using acidified ethanol, sodium dimethyl 
sulfoxide or sodium dodecyl sulphate in dilute hydrochloric acid. The cytotoxicity of polymer 
coated only as well as polymer & doxycycline hyclate coated dental implants was evaluated by 
means of the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. Normal 
gingival fibroblasts were cultured and plated (1x105 cells) in a 6 well dish. 
 
 
 
B.9 Differential Scanning Calorimetry: 
 
Differential scanning calorimetry (TA Instruments, Discovery Series, Delaware, USA) was 
used to assess the thermal properties and compatibility of polymers and doxycycline. Samples 
weighing between 5 to 10 mg were hermetically sealed in an aluminum pan and heated at a rate 
of 10º Celsius per minute from 25 º to 150 º Celsius. Ultra-pure nitrogen was used as the purge gas 
at a flow rate of 50 ml/min. 
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B.10 Contact angle measurement: 
 
Contact angle measurement was used to determine the effect of coating on the wetting 
behavior of titanium surface. Attension Theta equipment was used for measurement of contact 
angle (Biolin Scientific, USA). The equipment has to be calibrated prior to use. The Young- 
Laplace fitting mode was used for calculating the contact angle. OneAttension software was used 
to measure and calculate the contact angle. 
 
 
B.11.Formulation optimization: 
 
Formulation Hyaluronic 
acid % 
Chitosan 
(LMWWS) 
% 
Doxycycline 
hyclate % 
Result 
F1 1% 1% 600mg low viscosity of hyaluronic acid 
and chitosan solution, a 
flocculated solution of chitosan- 
doxycycline hyclate was 
obtained. 
F2 2% 2% 500mg Low viscosity of hyaluronic 
acid and chitosan, chitosan- 
doxycycline hyclate complex 
shows flocculation in spite of 
rapid vortex mixing and 
heating. 
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F3 3% 3% 450mg Low viscosity of hyaluronic 
acid and chitosan, chitosan- 
doxycycline complex shows 
some flocculation. 
F4 4% 4% 375mg Hyaluronic acid and chitosan 
are free-flowing and the 
chitosan-doxycycline complex 
doesn’t show any flocculation 
of doxycycline hyclate particles. 
F5 5% 5% 375mg The viscosity of hyaluronic acid 
and chitosan solution increases, 
problems were encountered in 
the coating process. 
F6 6% 6% 375mg Very high viscosity, unable to 
proceed with coating, coating 
process becomes uncontrollable. 
 
 
B.11.1 Optimization of the polymer concentration: 
 
PLGA% Result for 
 
PLGA 
Polycaprolactone% Result for polycaprolactone 
2% Low 
viscosity, 
free-flowing, 
2% Low viscosity, free-flowing 
solution, thin coating achieved. 
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 coating 
thickness was 
compromised. 
  
3% Low 
viscosity, 
free-flowing, 
coating 
thickness was 
compromised. 
3% Viscosity increased but still the 
viscosity was low which affected 
the thickness and the coating 
process. 
4% Viscosity was 
neither too 
low nor too 
high, was 
appropriate 
for coating 
process to 
proceed. 
4% Viscosity increased further but 
still was low which affected the 
coating thickness and process. 
5% Viscosity 
increased 
giving a gel- 
like 
consistency, 
5% Optimum viscosity achieved, 
neither too free flowing nor to 
gel-like, appropriate for the 
coating process. 
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CHAPTER 3 
RESULTS AND DISCUSSION
31 
 
 
C.1 Scanning electron microscopy: 
 
The Scanning electron microscopy samples were divided into three groups 
namely the uncoated (blank), the second group comprising of samples made up of hyaluronic 
acid, chitosan (LMWWS) and doxycycline hyclate, the third group comprising of samples 
made up of hyaluronic acid, chitosan (LMWWS) and PLGA. The levels of titanium were 
checked in different groups and it can be said that for uncoated titanium implants, the levels of 
titanium are higher when compared to implants coated with polymer. As the implants are 
coated with a mixture of polymers, the level of titanium reduces whereas the level of organic 
content increases concurrently. 
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Figure.3 Uncoated titanium dental implant at 1X magnification 
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Figure.4 Elemental analysis of spectrum 13 of uncoated titanium implants 
 
Figure.4 represents spectrum 13, from the spectrum it can be inferred that the level of 
titanium is higher than the organic content present on the uncoated dental implant. 
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Figure.5 Comparison of %weight of each element of uncoated dental implant 
 
From figure.5, it can be inferred that the % weight of titanium is higher than the % weight 
of organic content over uncoated dental implants. This proves that the implants have not been 
coated with any polymers or the active pharmaceutical ingredient. 
 
 
Figure.6 Titanium implant coated with layers of hyaluronic acid, chitosan (LMWWS) and 
doxycycline hyclate. 
Figure.6. represents implant coated with polymer layer of hyaluronic acid, chitosan 
(LMWWS) and doxycycline hyclate. There are four zones that have been focused upon in this 
region denoted as spectrum 15,16,17,18,19,20. 
35 
 
 
 
Figure.7 Elemental analysis of spectrum 17 of implant coated with layers of hyaluronic 
acid, chitosan (LMWWS) and doxycycline hyclate. 
Figure.7 represents spectrum 17 from figure.6, the spectrum indicates that the organic 
content of layer by layer coated implants is way higher than the titanium content of the dental 
implant thus, indicating that coating was successful. 
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Figure.8 Comparison of %weight of each element of coated dental implants 
 
From figure.8, it can be seen that the % weight of carbon has increased but the % weight 
of oxygen still remained the same as uncoated dental implants. The % weight titanium have 
reduced for coated implants. Thus, it can be said that coating was successful on account of 
reduction in the % weight levels of titanium and subsequent increase in the levels of carbon. 
 
 
C.2 Contact angle measurement: 
 
The samples were titanium discs divided into two groups to check out for a difference in 
the contact angle between uncoated and coated titanium disc. The coated discs were again divided 
into three groups, each group containing three titanium discs (n=3) namely: Group A is the control, 
Group B consisting of Hyaluronic acid and chitosan, Group C consisting of Hyaluronic acid, 
chitosan and PLGA and the final group, Group D consisting of Hyaluronic acid, Chitosan and 
Polycaprolactone. The samples were placed on a magnetic holder which is called as “sample stage”. 
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Each sample was analyzed for a period of 100 seconds in order to allow for the water droplet to 
stabilize over that period. The water droplet stabilizes over a period of 60 to 80 seconds. 
 
 
(A) (B) (C) (D) 
 
Figure.9 Contact angle images of different formulations 
Figure (A) represents an uncoated titanium disc (Control), the mean contact angle was 
found to be 34.11 º which shows that the titanium disc surface is hydrophilic in nature. 
Figure (B) represents the coated titanium disc. The titanium disc was coated with a polymer 
combination of Hyaluronic acid, Chitosan and Doxycycline hyclate. The mean contact angle 
dropped from 34.11 º to 16.83 º indicating an increase in the hydrophilicity imparted by the 
polymer combination. 
Figure (C) represents titanium disc coated with a polymer combination of hyaluronic acid, 
Chitosan, Doxycycline Hyclate and PLGA. The mean contact angle rose from 34.11 º to 62.16 º. 
This increase in contact angle indicates that PLGA as a polymer is imparting hydrophobicity to 
the formulation. In spite of increase in the contact angle, the final formulation still is hydrophilic 
since the contact angle is below 90 º. 
Figure (D) represents titanium disc coated with a polymer combination of hyaluronic acid, 
Chitosan, Doxycycline hyclate and Polycaprolactone. The mean contact angle rose from 34.11 º 
to 67 º. The increase in the contact angle indicates that Polycaprolactone as a polymer is imparting 
hydrophobicity to the final formulation. In spite of the increase in the contact angle, the final 
formulation is still hydrophilic in nature since the contact angle is below 90 º. 
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Figure.10 Comparison of the contact angle of different formulations (n=3) 
 
From figure.10, it can be seen that polycaprolactone and PLGA coated formulations 
showed a higher degree of hydrophobicity as compared to the control (uncoated disc) and the 
hyaluronic acid and chitosan coated discs. 
Hydrophobic polymers are imparting a hydrophobic character to the entire formulation. 
The hydrophobicity of polycaprolactone is higher when compared with other formulations in this 
study. Although, the hydrophobic polymers are increasing the contact angle by a factor of about 
50 º (±10 º), still the formulations are hydrophilic in nature because contact angle is less than 90 º. 
A hydrophilic formulation is desired in this study because a hydrophilic implant interacts to a 
larger extent with the biological fluids, tissues and the process of osseointegeration will be initiated 
at the earliest. 
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C.3 Differential Scanning Calorimetry: 
 
 
 
Figure.11 Differential Scanning Calorimetry of API and Polymers 
 
The differential scanning studies were conducted on pure drug and polymer. The results of 
the study are shown in the figure.11. From the thermogram, it can be reported that 
polycaprolactone shows a melting point of 60º Celsius. Chitosan shows a melting temperature of 
220º Celsius but being amorphous in nature, the melting point is not sharp at 220 º Celsius, chitosan 
undergoes degradation rather than melting. Doxycycline hyclate shows melting point around 230º 
Celsius. Hyaluronic acid being amorphous in nature, does not show a clear melting point. 
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Figure.12 Differential scanning thermogram of different formulations. 
 
The red line in figure 12. represents the thermogram of the polymer and API combination 
of hyaluronic acid, chitosan (LMWWS), doxycycline hyclate and PLGA.The formulation shows 
a sharp endothermic peak at 195º Celsius indicating melting point of the formulation. 
The blue line in figure 12. is the thermogram of polymer combination of hyaluronic acid, chitosan 
(LMWWS), doxycycline hyclate and polycaprolactone. The polymer combination shows a sharp 
endothermic peak at 55º Celsius which indicates the melting point of the melting point of the 
formulation. 
The green line represents the thermogram of hyaluronic acid, chitosan (LMWWS) and 
doxycycline hyclate. The formulation shoes a sharp endothermic peak at 100º Celsius which 
indicates the melting point of the formulation. 
There is a shift in the endothermic peaks of different formulations on account of various 
charge- based I interactions between different polymers of the formulation. The outermost layer 
of the 
41 
 
formulation determines to a larger extent the melting behavior of the entire formulation as seen in 
the thermogram. 
 
 
C.4 In-vitro release study: 
 
The implants were divided into five groups based on the polymer combination with which 
the implants were coated with: 
C.4.1 Implants coated only with Doxycycline: 
 
The implants were coated only with only doxycycline hyclate to assess the release profile 
pattern. It was found out that the release was rapid and swift with the release lasting for only about 
18 hours on an average for pH 6 and 7.4 respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.13 Release study of implants coated with doxycycline hyclate at pH 6.0 
 
As shown in Figure.13, it can be inferred that the release progressively increased until the 
12th hour and after that appeared to reach a plateau indicating that 100% drug was released from 
the polymer matrix by 18th hour. The total amount of drug released is around 90 mg (90,000µg) in 
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a span of 18 hours. It can be seen that at a lower pH, a higher amount of doxycycline hyclate is 
released from into the release medium. 
From the percentage release profile, it can be inferred that more than 50% of doxycycline 
hyclate has been released into the release medium by the 5th hour and by the 18th hour, a plateau is 
seen indicating a 100% release into the release medium. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.16 Release study of implants coated only with doxycycline hyclate at pH 7.4 
 
From figure.16, it can be inferred that the release progressively increased up until the 11th 
hour and appears to have reached a plateau by the 18th hour indicating 100% drug release from the 
polymer matrix into the release medium. The total amount of drug released is around 38 mg over 
a span of 18 hours. 
About 50% of doxycycline hyclate has been released by the 8th hour and by the 14th hour, 
it appears that a plateau has been reached. 
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Comparing figure 15 and 16, we can say that at a lower pH, the amount of doxycycline 
hyclate released is higher when compared with the amount of doxycycline hyclate released at an 
elevated pH. 
C.4.2 Implants coated with Hyaluronic acid, chitosan and doxycycline hyclate: 
 
The implants were coated in an alternating layer by layer fashion with Hyaluronic acid and 
Chitosan respectively. The release medium for this was phosphate buffer of pH 7.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.17 Release study of implants coated with hyaluronic acid, chitosan and doxycycline 
hyclate at pH 7.4 
It can be inferred from figure.17 that about 40 mg doxycycline hyclate has been released 
from the polymer matrix into the release medium over the span of 8 days. The release progressively 
increased up until the 6th day and after that appears to have reached a plateau by the 8th day 
indicating 100% release of doxycycline hyclate from the polymer matrix. 
From the percent release graph, it can be inferred that by the 3rd day, about 50% 
doxycycline hyclate has been released from the polymer matrix of hyaluronic acid and chitosan. 
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C.4.3 Implant coated with Hyaluronic acid, Chitosan, PLGA: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.18. Release study of implant coated with polymer combination of hyaluronic acid, 
chitosan, doxycycline and PLGA at pH 7.4 
From figure.18, it can be inferred that the release increased progressively until the 9th day 
 
and by the 11th day, a plateau appears to have reached indicating 100% release of doxycycline 
hyclate into the release medium. The total amount of drug released is around 12 mg over a period 
of 11 days. 
From the percent release graph, it can be seen that by the 1st day, a burst release has taken 
 
place which PLGA as a barrier polymer couldn’t control but soon after day 1, the release stabilized 
and a sustained release of doxycycline hyclate can be seen over a span of 11 days. 
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Figure.19 Release study of implant coated with hyaluronic acid, chitosan, doxycycline 
hyclate and PLGA at pH 5.0 
From figure.19, it can be inferred that the release continued to rise steadily until the 10th 
 
day and by the 11th day, it appears to have reached a plateau indicating a 100% release of 
doxycycline hyclate into the release medium. From the graph it can be inferred that 25 mg of 
doxycycline hyclate has been released over a span of 11 days. 
From the percent graph, it can be interpreted that within the 1st day, more than 50% of 
 
doxycycline hyclate has been released from the polymer matrix into the release medium which is 
the burst effect which is sufficient to kill any initial bacterial growth around the dental implant and 
in the vicinity. The release stabilized after day 1 and a concentration higher than the minimum 
inhibitory concentration has been achieved until day 11 after which, the amount of doxycycline 
released falls below the minimum inhibitory concentration. 
C.4.4 Alternating pH change release study: 
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Figure.20 Alternating release study at pH 7.4 and 5.0 
 
The main aim of this study was to evaluate the effect of change in pH on the release of 
doxycycline hyclate from the polymer matrix used for coating the dental implant. The release study 
was started with phosphate buffer of pH 7.4 and from figure.20, it can be seen that a burst release 
by day 1. The release for the next three days took place in phosphate buffer of pH 7.4 but on day 
5, the pH was replaced with same phosphate buffer but having a lower pH of 5.0 to assess the 
impact of lowering of pH on the release of doxycycline hyclate. As expected, the release jumped 
from 10.4 mg to 13.8 mg within a span of one day. The release ºsteadily rose until day 14 and 
appears to have reached a plateau by day 16, indicating a 100% release of doxycycline hyclate into 
the release medium. 
C.4.5 Implants coated with hyaluronic acid, chitosan, doxycycline hyclate and 
polycaprolactone: 
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Figure.21 Release study of implant coated with Hyaluronic acid, Chitosan, Doxycycline 
hyclate and Polycaprolactone 
From figure.21, it can be inferred that about 16 mg doxycycline hyclate was released from 
the polymer matrix into the release medium. A burst release can be seen on day 1 of about 8.5 mg 
but soon after that, the release stabilizes and a sustained release is obtained over a period of 21 
days. 
 
On the 14th day, the release medium was changed from pH 7.4 to pH 5.0 to check out for 
 
any change in the release profile pattern. It can be seen that a small spike in release can be seen on 
day 15 which continues to rise until day 17 after which, the release profile shows a plateau 
indicating 100% release from the polymer coating. 
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Figure.22 Release study of implants coated with Hyaluronic acid, Chitosan, Doxycycline 
hyclate and Polycaprolactone at pH 7.4 
From figure.22, it can be inferred that the total amount of drug released was about 20 mg 
which is higher than the amount of drug released at pH 7.4. The release continues to increase up 
until day 11 but appears to reach a plateau by the 15th day. It can thus be interpreted that by day 
20, 100 % doxycycline hyclate has been released into the release medium. 
It can be inferred from the release profile that hydrophobic polymers namely 
polycaprolactone and PLGA are providing a sustained release of doxycycline hyclate over an 
extended period of time as compared with other formulations made up of hyaluronic acid & 
chitosan and only doxycycline coated dental implants. The hydrophobic polymers provide a 
sustained release by preventing the entry of water into the polymer matrix. The layer by layer 
release system is sensitive to change in pH and as seen from the release profiles, lower pH 
promotes a higher release of doxycycline hyclate into the release medium. The reason for this 
behavior can be attributed to polymer and doxycycline hyclate behavior at different pH. At a lower 
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pH, the cationic nature of chitosan (LMWWS) is enhanced which causes the doxycycline hyclate- 
chitosan complex to weaken causing the release of free doxycycline hyclate into the release 
medium. A burst release is seen on account of swelling of polymer coating when placed in 
phosphate buffer. 
 
 
C.5 MTT Assay: 
 
Cytotoxicity of polymer coated dental implants was evaluated by means of the MTT (3- 
[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide) assay. Normal gingival fibroblasts 
were cultured and plated (1x105 cells) in a 6 well dish. Three implants from two experimental (100 
nm diameter, 180 nm diameter DINS) and one control group were placed in individual wells 
containing attached fibroblasts and incubated for three days. At the end of incubation period, the 
implants were removed and the cell viability was determined by MTT cell proliferation assay. 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure.23 MTT cytotoxicity assay 
 
The control shows a cell viability of 100% based on calculations using optical density. The 
cell viability is about 94.89 % in the presence of polymer and doxycycline hyclate coated dental 
implants. The cell viability is 92.49% in the presence of only polymer coated samples. The cell 
viability in the presence of uncoated dental implants is 93.39%. 
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The peri-dontal connective tissue contains a higher proportion of gingival fibroblasts cell 
type. These gingival fibroblasts are involved in periodontal tissue repair as well as mediate the 
inflammatory processes104. From the results of MTT assay, it can be interpreted that there is no 
significant difference between the different groups. Both the polymer and drug as well as only 
polymer coated implants are not cytotoxic towards human gingival fibroblasts. The cell viability 
of all the groups apart from control is more than 90 %. 
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CHAPTER 4 
  CONCLUSION 
53 
 
 
 
The layer by layer drug delivery system provides a sustained release of doxycycline 
hyclate depending upon the polymer used as barrier to control the release. The hydrophobic 
polymers provide a sustained release of the drug over a period ranging from up to 21 days, 
providing a concentration of doxycycline hyclate higher than minimum inhibitory concentration 
over that period. The layer by layer drug delivery system also shows sensitivity to change in pH 
with lower pH promoting an increase in the total amount of drug released. All the formulations 
are hydrophilic in nature which makes them ideal for ensuring a rapid osseointegeration and a 
higher level of interaction with the biological fluids and tissues. 
54 
 
 
 
 
 
                                                                          
 
 
 
 
 
                                                                    
                                                           
                                                                    BIBLIOGRAPHY
55 
 
1. Setzer FC, Kim S. Comparison of long-term survival of implants and endodontically 
treated teeth. J Dent Res. 2014;93(1):19-26. Doi:10.1177/0022034513504782 
2. Kohal RJ, Bächle M, Att W, et al. Osteoblast and bone tissue response to surface 
modified zirconia and titanium implant materials. Dent Mater. 2013;29:763-776. 
Doi:10.1016/j.dental.2013.04.003 
3. Al-Radha ASD, Dymock D, Younes C, O’Sullivan D. Surface properties of titanium and 
zirconia dental implant materials and their effect on bacterial adhesion. J Dent. 2012;40(2):146- 
153. Doi:10.1016/J.JDENT.2011.12.006 
4. Neoh KG, Hu X, Zheng D, Kang ET. Balancing osteoblast functions and bacterial 
adhesion on functionalized titanium surfaces. Biomaterials. 2012;33(10):2813-2822. 
Doi:10.1016/J.BIOMATERIALS.2012.01.018 
5. Preethanath RS, AlNahas NW, Bin Huraib SM, et al. Microbiome of dental implants 
and its clinical aspect. Microb Pathog. 2017;106:20-24. Doi:10.1016/J.MICPATH.2017.02.009 
6. Dhir S. Biofilm and dental implant: The microbial link. J Indian Soc Periodontol. 
 
2013;17(1):5-11. Doi:10.4103/0972-124X.107466 
 
7. Mah T-FC, O’Toole GA. Mechanisms of biofilm resistance to antimicrobial agents. 
 
Trends Microbiol. 2001;9(1):34-39. Doi:10.1016/S0966-842X(00)01913-2 
 
8. Fürst MM, Salvi GE, Lang NP, Persson GR. Bacterial colonization immediately after 
installation on oral titanium implants. Clin Oral Implants Res. 2007;18(4):501-508. 
Doi:10.1111/j.1600-0501.2007.01381.x 
9. Lv H, Chen Z, Yang X, Cen L, Zhang X, Gao P. Layer-by-layer self-assembly of 
minocycline-loaded chitosan/alginate multilayer on titanium substrates to inhibit biofilm 
formation. J Dent. 2014;42(11):1464-1472. Doi:10.1016/J.JDENT.2014.06.003 
56 
 
10. Prathapachandran J, Suresh N. Management of peri-implantitis. Dent Res J (Isfahan). 
 
2012;9(5):516-521. http://www.ncbi.nlm.nih.gov/pubmed/23559913. Accessed March 4, 2018. 
 
11. MOMBELLI A. Microbiology and antimicrobial therapy of peri-implantitis. Periodontol 
2000. 2002;28(1):177-189. Doi:10.1034/j.1600-0757.2002.280107.x 
12. Sung C-E, Chiang C-Y, Chiu H-C, Shieh Y-S, Lin F-G, Fu E. Periodontal status of 
tooth adjacent to implant with peri-implantitis. J Dent. 2018;70:104-109. 
Doi:10.1016/J.JDENT.2018.01.004 
13. Renvert S, Aghazadeh A, Hallström H, Persson GR. Factors related to peri-implantitis – 
a retrospective study. Clin Oral Implants Res. 2014;25(4):522-529. Doi:10.1111/clr.12208 
14. Renvert S, Polyzois I. Risk indicators for peri-implant mucositis: a systematic literature 
review. J Clin Periodontol. 2015;42:S172-S186. Doi:10.1111/jcpe.12346 
15. Heitz-Mayfield LJA. Peri-implant diseases: diagnosis and risk indicators. J Clin 
Periodontol. 2008;35(8 Suppl):292-304. Doi:10.1111/j.1600-051X.2008.01275.x 
16. Heydenrijk K, Meijer HJA, van der Reijden WA, Raghoebar GM, Vissink A, Stegenga 
 
B. Microbiota around root-form endosseous implants: a review of the literature. Int J Oral 
Maxillofac Implants. 17(6):829-838. http://www.ncbi.nlm.nih.gov/pubmed/12507243. 
Accessed 
March 4, 2018. 
 
17. Fda, Cder. ATRIDOX ® (doxycycline hyclate) 10% in the ATRIGEL ® Delivery 
System for controlled release in subgingival application. 
https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/050751s015lbl.pdf. Accessed April 
28, 2018. 
18. Ata-Ali J, Flichy-Fernández AJ, Alegre-Domingo T, Ata-Ali F, Palacio J, Peñarrocha- 
Diago M. Clinical, microbiological, and immunological aspects of healthy versus peri-
57 
 
implantitis 
58 
 
tissue in full arch reconstruction patients: a prospective cross-sectional study. BMC Oral 
Health. 2015;15(1):43. Doi:10.1186/s12903-015-0031-9 
19. Georgiev T. METHOD OF TREATMENT OF PERIIMPLANTITIS. J IMAB -Annual 
Proceeding (Scientific Pap. 2009;15(2). Doi:10.5272/jimab.1522009_14 
20. Smiler D, Soltan M. The Bone-Grafting Decision Tree: A Systematic Methodology for 
Achieving New Bone. Implant Dent. 2006;15(2):122-128. 
Doi:10.1097/01.id.0000217780.69637.cc 
21. Renvert S, Roos-Jansåker A-M, Claffey N. Non-surgical treatment of peri-implant 
mucositis and peri-implantitis: a literature review. J Clin Periodontol. 2008;35(8 Suppl):305-
315. Doi:10.1111/j.1600-051X.2008.01276.x 
22. Roos-Jansaker A-M, Lindahl C, Renvert H, Renvert S. Nine- to fourteen-year follow-up 
of implant treatment. Part II: presence of peri-implant lesions. J Clin Periodontol. 
2006;33(4):290-295. Doi:10.1111/j.1600-051X.2006.00906.x 
23. Esposito M, Dojcinovic I, Germon L, et al. Safety and efficacy of a biomimetic 
monolayer of permanently bound multi-phosphonic acid molecules on dental implants: 1 year 
post-loading results from a pilot quadruple-blinded 54haracteri controlled trial. Eur J Oral 
Implantol. 2013;6(3):227-236. http://www.ncbi.nlm.nih.gov/pubmed/24179977. Accessed 
March 4, 2018. 
24. Bosch-Aranda ML, Canalda-Sahli C, Figueiredo R, Gay-Escoda C. Complications 
following an accidental sodium hypochlorite extrusion: A report of two cases. J Clin Exp Dent. 
2012;4(3):e194-8. Doi:10.4317/jced.50767 
25. Lang NP, Berglundh T, Heitz-Mayfield LJ, Pjetursson BE, Salvi GE, Sanz M. 
Consensus statements and recommended clinical procedures regarding implant survival and 
complications. 
59 
 
Int J Oral Maxillofac Implants. 2004;19 Suppl:150-154. 
http://www.ncbi.nlm.nih.gov/pubmed/15635955. Accessed March 4, 2018. 
26. Mombelli A. Etiology, diagnosis, and treatment considerations in peri-implantitis. Curr 
Opin Periodontol. 1997;4:127-136. http://www.ncbi.nlm.nih.gov/pubmed/9655032. Accessed 
March 6, 2018. 
27. Büchter A, Meyer U, Kruse-Lösler B, Joos U, Kleinheinz J. Sustained release of 
doxycycline for the treatment of peri-implantitis: 55haracteri controlled trial. Br J Oral 
Maxillofac Surg. 2004;42:439-444. Doi:10.1016/j.bjoms.2004.06.005 
28. Norowski PA, Bumgardner JD. Biomaterial and antibiotic strategies for peri-implantitis: 
A review. J Biomed Mater Res Part B Appl Biomater. 2009;88B(2):530-543. 
Doi:10.1002/jbm.b.31152 
29. Misra R, Sahoo SK. Antibacterial Activity of Doxycycline-Loaded Nanoparticles. In: ; 
2012:61-85. Doi:10.1016/B978-0-12-391858-1.00004-6 
30. Saivin S, Houin G. Clinical Pharmacokinetics of Doxycycline and Minocycline. Clin 
Pharmacokinet. 1988;15(6):355-366. Doi:10.2165/00003088-198815060-00001 
31. Morozumi M, Okada T, Tajima T, Ubukata K, Iwata S. Killing kinetics of minocycline, 
doxycycline and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae. Int J 
Antimicrob Agents. 2017;50(2):255-257. Doi:10.1016/J.IJANTIMICAG.2017.02.027 
32. Makadia HK, Siegel SJ. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable 
Controlled Drug Delivery Carrier. Polymers (Basel). 2011;3(3):1377-1397. 
Doi:10.3390/polym3031377 
60 
 
33. Bosworth LA, Downes S. Physicochemical 56characterization of degrading 
polycaprolactone scaffolds. Polym Degrad Stab. 2010;95(12):2269-2276. 
Doi:10.1016/J.POLYMDEGRADSTAB.2010.09.007 
34. Yang Y, He Q, Duan L, Cui Y, Li J. Assembled alginate/chitosan nanotubes for 
biological application. Biomaterials. 2007;28:3083-3090. 
Doi:10.1016/j.biomaterials.2007.03.019 
35. Fraser JR, Laurent TC, Laurent UB. Hyaluronan: its nature, distribution, functions and 
turnover. J Intern Med. 1997;242(1):27-33. http://www.ncbi.nlm.nih.gov/pubmed/9260563. 
Accessed March 10, 2018. 
36. Necas J, Bartosikova L, Brauner P, Kolar J. Hyaluronic acid (hyaluronan): a review. Vet 
Med (Praha). 2008;53(8):397-411. https://www.vri.cz/docs/vetmed/53-8-397.pdf. Accessed 
March 10, 2018. 
37. Chen WYJ, Abatangelo G. Intercellular adhesion molecule-1 IL-1β Interleukin-1β 
Lymphocyte function associated-1 TNF-α Tumor necrosis factor-α Functions of hyaluronan in 
wound repair. 
https://pdfs.semanticscholar.org/7afc/636a44ea7da8b7eb9ca9721889c1edb265ab.pdf. Accessed 
March 10, 2018. 
38. Cheung RCF, Ng TB, Wong JH, Chan WY. Chitosan: An Update on Potential 
Biomedical and Pharmaceutical Applications. Mar Drugs. 2015;13(8):5156-5186. 
Doi:10.3390/md13085156 
39. Sudarshan NR, Hoover DG, Knorr D. Antibacterial action of chitosan. Food Biotechnol. 
 
1992;6(3):257-272. Doi:10.1080/08905439209549838 
61 
 
40. Rhoades J, Roller S. Antimicrobial actions of degraded and native chitosan against 
spoilage organisms in laboratory media and foods. Appl Environ Microbiol. 2000;66(1):80-86. 
http://www.ncbi.nlm.nih.gov/pubmed/10618206. Accessed March 10, 2018. 
41. Parts and Steps of a Dental Implant | Clinique dentaire ADF. 
https://treehouseileperrot.wordpress.com/2015/11/09/parts-and-steps-of-a-dental-implant/. 
Accessed April 28, 2018. 
42. Griggs JA. Dental Implants. Dent Clin North Am. 2017;61(4):857-871. 
 
Doi:10.1016/J.CDEN.2017.06.007 
 
43. Wilson TG, Valderrama P, Burbano M, et al. Foreign Bodies Associated With Peri- 
Implantitis Human Biopsies. J Periodontol. 2015;86(1):9-15. Doi:10.1902/jop.2014.140363 
44. Berglundh T, Persson L, Klinge B. A systematic review of the incidence of biological 
and technical complications in implant dentistry reported in prospective longitudinal studies of 
at least 5 years. J Clin Periodontol. 2002;29 Suppl 3:197-212-3. 
http://www.ncbi.nlm.nih.gov/pubmed/12787220. Accessed February 13, 2018. 
45. Papaspyridakos P, Mokti M, Chen C-J, Benic GI, Gallucci GO, Chronopoulos V. 
Implant and Prosthodontic Survival Rates with Implant Fixed Complete Dental Prostheses in 
the Edentulous Mandible after at Least 5 Years: A Systematic Review. Clin Implant Dent Relat 
Res. 2014;16(5):705-717. Doi:10.1111/cid.12036 
46. Pjetursson BE, Thoma D, Jung R, Zwahlen M, Zembic A. A systematic review of the 
survival and complication rates of implant-supported fixed dental prostheses (FDPs) after a 
mean observation period of at least 5 years. Clin Oral Implants Res. 2012;23:22-38. 
Doi:10.1111/j.1600-0501.2012.02546.x 
62 
 
47. What are Dental Implants – Types of Dental Implants | Colgate. 
https://www.colgate.com/en-us/oral-health/cosmetic-dentistry/implants/what-are-dental- 
implants. Accessed April 28, 2018. 
48. Types of dental implants include endosseous implants, subperiosteal implants, and 
transosteal implants. http://dentalimplants.uchc.edu/about/types.html. Accessed April 28, 2018. 
49. Rupp F, Liang L, Geis-Gerstorfer J, Scheideler L, Hüttig F. Surface characteristics of 
dental implants: A review. Dent Mater. 2018;34(1):40-57. 
Doi:10.1016/J.DENTAL.2017.09.007 
50. Lotz EM, Olivares-Navarrete R, Berner S, Boyan BD, Schwartz Z. Osteogenic response 
of human MSCs and osteoblasts to hydrophilic and hydrophobic nanostructured titanium 
implant surfaces. J Biomed Mater Res Part A. 2016;104(12):3137-3148. 
Doi:10.1002/jbm.a.35852 
51. Martin JY, Schwartz Z, Hummert TW, et al. Effect of titanium surface roughness on 
proliferation, differentiation, and protein synthesis of human osteoblast-like cells (MG63). J 
Biomed Mater Res. 1995;29(3):389-401. Doi:10.1002/jbm.820290314 
52. Kennedy SB, Washburn NR, George Simon Jr C, Amis EJ. Combinatorial screen of the 
effect of surface energy on fibronectin-mediated osteoblast adhesion, spreading and 
proliferation. Biomaterials. 2006;27:3817-3824. Doi:10.1016/j.biomaterials.2006.02.044 
53. Park JH, Olivares-Navarrete R, Wasilewski CE, Boyan BD, Tannenbaum R, Schwartz 
Z. Use of polyelectrolyte thin films to modulate Osteoblast response to microstructured 
titanium surfaces. 2012. Doi:10.1016/j.biomaterials.2012.03.074 
54. Kim I-H, Kwon T-Y, Kim K-H. TOP 1% Selection of our books indexed in the Book 
Citation Index in Web of ScienceTM Core Collection (BKCI) Wetting Behavior of Dental 
Implants. 3. http://www.intechopen.com/books/wetting-and-wettability. Accessed February 21, 
63 
 
2018. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
64 
 
55. Schwartz Z, Boyan BD. Underlying mechanisms at the bone-biomaterial interface. J 
Cell Biochem. 1994;56(3):340-347. Doi:10.1002/jcb.240560310 
56. Kasemo B, Lausmaa J. Material-tissue interfaces: the role of surface properties and 
processes. Environ Health Perspect. 1994;102 Suppl 5(Suppl 5):41-45. 
http://www.ncbi.nlm.nih.gov/pubmed/7882954. Accessed February 26, 2018. 
57. Gupta S, Dahiya V, Shukla P. Surface topography of dental implants: A review. J Dent 
Implant. 2014;4(1):66. Doi:10.4103/0974-6781.131009 
58. Mendoza-Arnau A, Vallecillo-Capilla M-F, Cabrerizo-Vílchez M-Á, Rosales-Leal J-I. 
Topographic 59haracterization of dental implants for commercial use. Med Oral Patol Oral Cir 
Bucal. 2016;21(5):e631-6. Doi:10.4317/MEDORAL.20333 
59. Buser D, Schenk RK, Steinemann S, Fiorellini JP, Fox CH, Stich H. Influence of 
surface characteristics on bone integration of titanium implants. A histomorphometric study in 
miniature pigs. J Biomed Mater Res. 1991;25(7):889-902. Doi:10.1002/jbm.820250708 
60. Montero J, Bravo M, Guadilla Y, et al. Comparison of Clinical and Histologic 
Outcomes of Zirconia Versus Titanium Implants Placed in Fresh Sockets: A 5-Month Study in 
Beagles. Int J Oral Maxillofac Implants. 2015;30(4):773-780. Doi:10.11607/jomi.3668 
61. Novaes Jr AB, Souza SLS de, Barros RRM de, Pereira KKY, Iezzi G, Piattelli A. 
Influence of implant surfaces on osseointegration. Braz Dent J. 2010;21(6):471-481. 
Doi:10.1590/S0103-64402010000600001 
62. Szmukler-Moncler S, Testori T, Bernard JP. Etched implants: A comparative surface 
analysis of four implant systems. J Biomed Mater Res. 2004;69B(1):46-57. 
Doi:10.1002/jbm.b.20021 
65 
 
63. Wennerberg A, Albrektsson T. Effects of titanium surface topography on bone 
integration: a systematic review. Clin Oral Implants Res. 2009;20:172-184. 
Doi:10.1111/j.1600- 0501.2009.01775.x 
64. Yadav A, Yadav R, Gupta A, Baranwal A, Bhatnagar A, Singh V. Effect of Ultraviolet 
Irradiation on the Osseointegration of a Titanium Alloy with Bone. Contemp Clin Dent. 
2017;8(4):571-578. Doi:10.4103/ccd.ccd_576_17 
65. Brett P., Harle J, Salih V, et al. Roughness response genes in osteoblasts. Bone. 
 
2004;35(1):124-133. Doi:10.1016/j.bone.2004.03.009 
 
66. Li X, Huang Y, Zheng L, et al. Effect of substrate stiffness on the functions of rat bone 
marrow and adipose tissue derived mesenchymal stem cells in vitro. J Biomed Mater Res Part 
A. 2014;102(4):1092-1101. Doi:10.1002/jbm.a.34774 
67. Gittens RA, Scheideler L, Rupp F, et al. A review on the wettability of dental implant 
surfaces II: Biological and clinical aspects. Acta Biomater. 2014;10(7):2907-2918. 
Doi:10.1016/J.ACTBIO.2014.03.032 
68. Zhao G, Schwartz Z, Wieland M, et al. High surface energy enhances cell response to 
titanium substrate microstructure. J Biomed Mater Res Part A. 2005;74A(1):49-58. 
Doi:10.1002/jbm.a.30320 
69. Rupp F, Gittens RA, Scheideler L, et al. A review on the wettability of dental implant 
surfaces I: Theoretical and experimental aspects. Acta Biomater. 2014;10(7):2894-2906. 
Doi:10.1016/J.ACTBIO.2014.02.040 
70. Smeets R, Stadlinger B, Schwarz F, et al. Impact of Dental Implant Surface 
Modifications on Osseointegration. Biomed Res Int. 2016;2016:6285620. 
Doi:10.1155/2016/6285620 
66 
 
71. Rupp F, Scheideler L, Eichler M, Geis-Gerstorfer J. Wetting behavior of dental 
implants. 
 
Int J Oral Maxillofac Implants. 26(6):1256-1266. 
http://www.ncbi.nlm.nih.gov/pubmed/22167431. Accessed February 19, 2018. 
72. Schwarz F, Wieland M, Schwartz Z, et al. Potential of chemically modified hydrophilic 
surface characteristics to support tissue integration of titanium dental implants. J Biomed Mater 
Res Part B Appl Biomater. 2009;88B(2):544-557. Doi:10.1002/jbm.b.31233 
73. Rupp F, Scheideler L, Olshanska N, de Wild M, Wieland M, Geis-Gerstorfer J. 
Enhancing surface free energy and hydrophilicity through chemical modification of 
microstructured titanium implant surfaces. J Biomed Mater Res Part A. 2006;76A(2):323-334. 
Doi:10.1002/jbm.a.30518 
74. Rosina J, Kvasnák E, Suta D, Kolárová H, Málek J, Krajci L. Temperature dependence 
of blood surface tension. Physiol Res. 2007;56 Suppl 1:S93-8. 
http://www.ncbi.nlm.nih.gov/pubmed/17552890. Accessed February 21, 2018. 
75. Hilditch CJ, McEvoy RD, George KE, et al. Upper airway surface tension but not upper 
airway collapsibility is elevated in primary Sjögren’s syndrome. Sleep. 2008;31(3):367-374. 
http://www.ncbi.nlm.nih.gov/pubmed/18363313. Accessed February 21, 2018. 
76. Zhao F, Wang J, Guo H, Liu S, He W. The Effects of Surface Properties of 
Nanostructured Bone Repair Materials on Their Performances. J Nanomater. 2015;2015:1-11. 
Doi:10.1155/2015/893545 
77. Han A, Tsoi JKH, Rodrigues FP, Leprince JG, Palin WM. Bacterial adhesion 
mechanisms on dental implant surfaces and the influencing factors. Int J Adhes Adhes. 
2016;69:58-71. Doi:10.1016/J.IJADHADH.2016.03.022 
67 
 
78. Li X, Gao H, Uo M, et al. Maturation of osteoblast-like SaoS2 induced by carbon 
nanotubes. Biomed Mater. 2009;4(1):15005. Doi:10.1088/1748-6041/4/1/015005 
79. Facca S, Lahiri D, Fioretti F, et al. In Vivo Osseointegration of Nano-Designed 
Composite Coatings on Titanium Implants. ACS Nano. 2011;5(6):4790-4799. 
Doi:10.1021/nn200768c 
80. Balani K, Anderson R, Laha T, et al. Plasma-sprayed carbon nanotube reinforced 
hydroxyapatite coatings and their interaction with human osteoblasts in vitro. Biomaterials. 
2007;28(4):618-624. Doi:10.1016/j.biomaterials.2006.09.013 
81. Lahiri D, Benaduce AP, Rouzaud F, et al. Wear behavior and in vitro cytotoxicity of 
wear debris generated from hydroxyapatite-carbon nanotube composite coating. J Biomed 
Mater Res Part A. 2011;96A(1):1-12. Doi:10.1002/jbm.a.32952 
82. Ertel SI, Ratner BD, Horbett TA. Radiofrequency plasma deposition of oxygen- 
containing films on polystyrene and poly(ethylene terephthalate) substrates improves 
endothelial cell growth. J Biomed Mater Res. 1990;24(12):1637-1659. 
Doi:10.1002/jbm.820241207 
83. Pettit DK, Horbett TA, Hoffman AS. Influence of the substrate binding characteristics 
of fibronectin on corneal epithelial cell outgrowth. J Biomed Mater Res. 1992;26(10):1259-
1275. Doi:10.1002/jbm.820261002 
84. Sartoretto SC, Alves ATNN, Resende RFB, Calasans-Maia J, Granjeiro JM, Calasans- 
Maia MD. Early osseointegration driven by the surface chemistry and wettability of dental 
implants. J Appl Oral Sci. 2015;23(3):279-287. Doi:10.1590/1678-775720140483 
85. Textor M, Sittig C, Frauchiger V, Tosatti S, Brunette DM. Properties and Biological 
Significance of Natural Oxide Films on Titanium and Its Alloys. In: Springer, Berlin, 
Heidelberg; 2001:171-230. Doi:10.1007/978-3-642-56486-4_7 
68 
 
86. Michiardi A, Aparicio C, Ratner BD, Planell JA, Gil J. The influence of surface energy 
on competitive protein adsorption on oxidized NiTi surfaces. Biomaterials. 2007;28(4):586-
594. Doi:10.1016/J.BIOMATERIALS.2006.09.040 
87. Doundoulakis JH. Surface analysis of titanium after sterilization: Role in implant-tissue 
interface and bioadhesion. J Prosthet Dent. 1987;58(4):471-478. Doi:10.1016/0022- 
3913(87)90279-4 
88. Han A, Tsoi JKH, Rodrigues FP, Leprince JG, Palin WM. Bacterial adhesion 
mechanisms on dental implant surfaces and the influencing factors. Int J Adhes Adhes. 
2016;69:58-71. Doi:10.1016/J.IJADHADH.2016.03.022 
89. Chen X, Hirt H, Li Y, Gorr S-U, Aparicio C. Antimicrobial GL13K Peptide Coatings 
Killed and Ruptured the Wall of Streptococcus gordonii and Prevented Formation and Growth 
of Biofilms. Kreth J, ed. PloS One. 2014;9(11):e111579. Doi:10.1371/journal.pone.0111579 
90. Heo S-M, Ruhl S, Scannapieco FA. Implications of salivary protein binding to 
commensal and pathogenic bacteria. J Oral Biosci. 2013;55:169-174. 
Doi:10.1016/j.job.2013.06.004 
91. Cai K, Delaviz Y, Banh M, Guo Y, Santerre JP. ScienceDirect Biodegradation of 
composite resin with ester linkages: Identifying human salivary enzyme activity with a potential 
role in the esterolytic process. Dent Mater. 2014;30:848-860. Doi:10.1016/j.dental.2014.05.031 
92. Bourbia M, Ma D, Cvitkovitch DG, Santerre JP, Finer Y. Cariogenic Bacteria Degrade 
Dental Resin Composites and Adhesives. J Dent Res. 2013;92(11):989-994. 
Doi:10.1177/0022034513504436 
93. Okada M, Sato I, Cho SJ, et al. Structure of the Bacillus subtilis quorum-sensing peptide 
pheromone ComX. Nat Chem Biol. 2005;1(1):23-24. Doi:10.1038/nchembio709 
69 
 
94. Jamal M, Tasneem U, Hussain T, Andleeb S. Bacterial Biofilm: Its Composition, 
Formation and Role in Human Infections. Res Rev J Microbiol Biotechnol. 2015;4(3). 
http://www.rroij.com/open-access/pdfdownload.php?download=open-access/bacterial-biofilm- 
its-composition-formation-and-role-in-human-infections.pdf&aid=61426. Accessed March 6, 
2018. 
95. Sauer FG, Remaut H, Hultgren SJ, Waksman G. Fiber assembly by the chaperone–usher 
pathway. Biochim Biophys Acta – Mol Cell Res. 2004;1694(1-3):259-267. 
Doi:10.1016/j.bbamcr.2004.02.010 
96. Saxton CA. Scanning Electron Microscope Study of the Formation of Dental Plaque. 
 
Caries Res. 1973;7(2):102-119. Doi:10.1159/000259835 
 
97. Gibbons RJ, Houte J Van. On the Formation of Dental Plaques. J Periodontol. 
 
1973;44(6):347-360. Doi:10.1902/jop.1973.44.6.347 
 
98. Naves P, del Prado G, Huelves L, et al. Effects of human serum albumin, ibuprofen and 
N-acetyl-l-cysteine against biofilm formation by pathogenic Escherichia coli strains. J Hosp 
Infect. 2010;76(2):165-170. Doi:10.1016/j.jhin.2010.05.011 
99. Kolenbrander PE, Andersen RN, Blehert DS, Egland PG, Foster JS, Palmer RJ. 
Communication among oral bacteria. Microbiol Mol Biol Rev. 2002;66(3):486-505, table of 
contents. http://www.ncbi.nlm.nih.gov/pubmed/12209001. Accessed March 6, 2018. 
100. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious 
biofilms. 
 
Trends Microbiol. 2005;13(1):34-40. Doi:10.1016/j.tim.2004.11.010 
 
101. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of 
persistent infections. Science. 1999;284(5418):1318-1322. 
http://www.ncbi.nlm.nih.gov/pubmed/10334980. Accessed March 7, 2018. 
70 
 
102. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant 
microorganisms. Clin Microbiol Rev. 2002;15(2):167-193. 
http://www.ncbi.nlm.nih.gov/pubmed/11932229. Accessed March 7, 2018. 
103. McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA, Pier GB. The ica locus of 
Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect 
Immun. 1998;66(10):4711-4720. http://www.ncbi.nlm.nih.gov/pubmed/9746568. Accessed 
March 7, 2018. 
104. Parsek MR, Singh PK. Bacterial Biofilms: An Emerging Link to Disease Pathogenesis. 
 
Annu Rev Microbiol. 2003;57(1):677-701. Doi:10.1146/annurev.micro.57.030502.090720 
 
105. Lee I, Lee M, Jang H-S. The interrelationship between human gingival fibroblast 
differentiation and cultivating time. Tissue Eng Regen Med. 2013;10(2):60-64. 
Doi:10.1007/s13770-013-0371-y 
71 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VITA 
 
Sagar Deepak Sawant a native of Thane, India received his bachelor’s in Pharmaceutical 
Sciences from the University of Mumbai in the year 2016. Thereafter, he joined the University 
of Mississippi as a Master’s student at the Department of Pharmaceutics and Drug delivery. He 
has an active interest in polymer-based drug delivery systems and has a keen interest in that 
field of study. He is an active member of American Association of Pharmaceutical Scientist 
(AAPS). He will receive his Master’s in Pharmaceutical Sciences in May 2018 and plans to 
work after his Master’s education. 
